Preview

Healthcare

Healthcare

Advanced search

Symptoms of atopic dermatitis in children (ISAAC): a comparative cross-sectional study after 15 years

https://doi.org/10.65249/1027-7218-2026-8-19-26

Abstract

Objective. To conduct a comparative analysis of the frequency of atopic dermatitis symptoms in children of the Grodno region over a 15-year period (2008–2023) to assess long-term dynamics.
Materials and methods. The frequency of atopic dermatitis symptoms was studied using the ISAAC questionnaire in 2873 children (6–7 years old, n = 1694; 13–14 years old, n = 1179) in 2023. The results were compared with the results of studies we conducted using a similar methodology in 2008 and 2014.
Results. In children aged 6–7 years and 13–14 years, the frequency of itchy rash in the last 12 months was 10.3 % (95 % CI (8.9–11.9)) and 7.1 % (95 % CI (5.8–8.8)), severe symptoms of atopic dermatitis 0.6 % (95 % CI (0.3–1.1)) and 0.4 % (95 % CI (0.2–1.0)), diagnosis of eczema, neurodermatitis, atopic dermatitis, established sometime before the survey 18.5 % (95 % CI (16.7–20.4)) and 13.9 (95 % CI (12.0–16.1)), respectively. Over a 15-year period (2008–2023), an increase in the frequency of itchy rash on the elbows, behind the knees, in front of the ankles, under the buttocks, around the neck, eyes, and ears was observed in children aged 6–7 years (p = 0.0004); a diagnosis of eczema, neurodermatitis, or atopic dermatitis, established at some time (p < 0.0001) before the survey. In children aged 13–14 years, an increase in the frequency of itchy rash that appeared and disappeared within 6 months (p < 0.0001); itchy rash in the last 12 months (p < 0.0001); lesions with itchy rash on the elbows, behind the knees, in front of the ankles, under the buttocks, around the neck, eyes, ears (p < 0.0001); diagnosis of eczema, neurodermatitis, atopic dermatitis, established at some time before the survey (p < 0.0001).
Conclusion. Over the course of 15 years, unidirectional dynamic trends in the frequency of atopic dermatitis symptoms have been established in both children aged 6-7 years and adolescents aged 13–14 years.

About the Authors

N. Khokha
Гродненский государственный медицинский университет
Belarus


V. Ravskaya
Гродненский государственный медицинский университет
Belarus


N. Paramonova
Гродненский государственный медицинский университет
Belarus


References

1. Narla S., Silverberg J.I. Current updates in the epidemiology and comorbidities of atopic dermatitis. Ann Allergy Asthma Immunol. 2025; 135(5): 511–520.

2. Jin L., Ge J., Cheng Y., et al. Worldwide prevalence of atopic dermatitis in children between 2000 and 2021. Ann Allergy Asthma Immunol. 2025; 134(5): 603–609.

3. Ilic I., Stojkovic A., Velickovic V., et al. Atopic Dermatitis in Children Under 5: Prevalence Trends in Central, Eastern, and Western Europ. Children. 2023; 10(8). https://doi.org/10.3390/children10081275.

4. Odhiambo J.A., Williams H.C., Clayton T.O., et al. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol. 2009; 124(6). doi: 10.1016/j.jaci.2009.10.009.

5. Langan S. M., Mulick A. R., Rutter C. E., et al. Trends in eczema prevalence in children and adolescents. Clin Exp Allergy. 2023; 53: 337–352.

6. Cabrera A., Picado C., Rodriguez A., et al. Asthma, rhinitis and eczema symptoms in Quito, Ecuador. BMJ Open Resp Res. 2021; 8. doi:10.1136/bmjresp-2021-001004.

7. Khokha, R. N. или Hoha R.N. Prevalence of symptoms of allergic diseases among children of the Grodno region (Republic of Belarus). Rossijskij allergologicheskij zhurnal. 2014; 11(5): 46–50. (in Russian)

8. Khokha, R. N. или Hoha R.N. Dynamics of the prevalence of atopic dermatitis symptoms in children (according to the results of Phase III, ISAAC) in a separate administrative-territorial region of the Republic of Belarus (Grodno region). Zhurnal Grodnenskogo gosudarstvennogo medicinskogo universiteta. 2016; 1: 45–50. (in Russian).

9. Asher M. I., Keil U., Anderson H.R., et al. International study of asthma and allergies in childhood (ISAAC): rationale and methods. Eur Respir J. 1995; 8: 483–491.

10. Garcia-Marcos L., Asher M.I., Pearce N., et al. The burden of asthma, hay fever and eczema in children in 25 countries. Eur Respir J. 2022; 60(3). doi: 10.1183/13993003.02866-2021.

11. Blakeway H., Van-de-Velde V., Allen V.B., et al. What is the evidence for interactions between filaggrin null mutations and environmental exposures in the aetiology of atopic dermatitis? Br J Dermatol. 2020; 183(3): 443–451.

12. Kelleher M., Dunn-Galvin A., Hourihane J.O., et al. Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and predicts atopic dermatitis at 1 year. J Allergy Clin Immunol. 2015; 135(4). doi: 10.1016/j.jaci.2014.12.013.

13. Kelleher M.M., Cro S., Cornelius V., et al. Skin care interventions in infants for preventing eczema and food allergy. Cochrane Database Syst Rev. 2021; 2. doi: 10.1002/14651858.CD013534.pub2.

14. Simpson E.L., Michaels L.C., Ramsey K., et al. Emollients to prevent pediatric eczema. JAMA Dermatol. 2025; 161(9): 95–65.

15. Ryczaj K., Leung D.Y.M., Venter C., et al. Emollient formulations and skin barrier practices in the context of eczema and food allergy prevention. Allergy. 2026. doi.org/10.1111/all.70404.

16. Murashkin N.N., Ivanov R.A., Fyodorov D.V., et al. The role of emollients in preventing the development of allergic diseases against the background of atopic dermatitis in children Pediatricheskaya farmakologiya. 2020; 17(4). doi.org/10.15690/pf.v17i4.2160. (in Russian)


Review

For citations:


Khokha N., Ravskaya V., Paramonova N. Symptoms of atopic dermatitis in children (ISAAC): a comparative cross-sectional study after 15 years. Healthcare. 2026;(8):19-26. (In Russ.) https://doi.org/10.65249/1027-7218-2026-8-19-26

Views: 133

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1027-7218 (Print)